SCHEMBL973523

SCHEMBL973523

CC(C(=O)NCCC1CCCCCCC1)N1CCNCC1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 4/20 1.00
BCHE P06276 2/20 0.46
ITGB3 P05106 2/20 0.45
ITGA2B P08514 2/20 0.45
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
EPHX1 P07099 1/20 0.42
ALDH1A1 P00352 2/20 0.40
TPSAB1 Q15661 1/20 0.40
TPSD1 Q9BZJ3 1/20 0.40
TPSG1 Q9NRR2 1/20 0.40
GAA P10253 1/20 0.40
KDM4E B2RXH2 2/20 0.40
OPRM1 P35372 1/20 0.37
OPRD1 P41143 1/20 0.37
OPRK1 P41145 1/20 0.37
CHRM5 P08912 2/20 0.37
CHRM3 P20309 2/20 0.37
F2R P25116 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24322648 0.86 SIGMAR1 (0.76) SIGMAR1MEN1KMT2AEPHX1ALDH1A1
SCHEMBL975229 0.81 SIGMAR1 (1.00) SIGMAR1BCHEMEN1KMT2AALDH1A1
SCHEMBL11066538 0.78 SIGMAR1 (0.63) SIGMAR1MEN1KMT2AKDM4EOPRM1
SCHEMBL9891794 0.76 SIGMAR1 (0.60) SIGMAR1BCHEEPHX1
SCHEMBL11070233 0.76 SIGMAR1 (0.60) SIGMAR1MEN1KMT2AEPHX1CHRM5
SCHEMBL11071000 0.76 KDM4E (0.65) SIGMAR1EPHX1ALDH1A1GAAKDM4E
SCHEMBL6678936 0.75 SIGMAR1 (0.58) SIGMAR1MEN1KMT2AKDM4EOPRM1
SCHEMBL8508634 0.74 SIGMAR1 (0.59) SIGMAR1ITGB3ITGA2BOPRD1CHRM5
SCHEMBL11066224 0.74 SIGMAR1 (0.59) SIGMAR1EPHX1
SCHEMBL24276406 0.74 SIGMAR1 (0.57) SIGMAR1BCHEEPHX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011000945-A9 AMINOALKAMIDES FOR USE IN THE TREATMENT OF INFLAMMATORY, DEGENERATIVE OR DEMYELINATING DISEASES OF THE CNS NENSIUS RESEARCH A/S (DK) 2011-04-07 WO claimed
WO-2011000945-A2 AMINOALKAMIDES FOR USE IN THE TREATMENT OF INFLAMMATORY, DEGENERATIVE OR DEMYELINATING DISEASES OF THE CNS NENSIUS RESEARCH A/S (DK) 2011-01-06 WO claimed
WO-2011000945-A9 AMINOALKAMIDES FOR USE IN THE TREATMENT OF INFLAMMATORY, DEGENERATIVE OR DEMYELINATING DISEASES OF THE CNS NENSIUS RESEARCH A/S (DK) 2011-04-07 WO disclosed
WO-2011000945-A2 AMINOALKAMIDES FOR USE IN THE TREATMENT OF INFLAMMATORY, DEGENERATIVE OR DEMYELINATING DISEASES OF THE CNS NENSIUS RESEARCH A/S (DK) 2011-01-06 WO disclosed